A relationship between HbA1c levels and emotional regulation in T1/T2 diabetes has been reported. Accordingly, we developed a 10-session Emotion-Focused Cognitive Behavioral Treatment (EF-CBT) program to address this issue. Twenty patients with T2D were equally randomized to EF-CBT and Treatment As Usual (TAU). While both displayed HbA1c reductions mid-trial, the EF-CBT group showed a larger reduction [-1.23 ± 1.11 (d = 1.11)] compared with TAU [-0.67 ± 1.11 (d = 0.61)]. The difference at end- (d = 0.49), but not mid- (d = 0.03) trial, is likely because most EF-CBT elements are after mid-trial. Correlations between changes in HbA1c levels and in diabetes distress (r = 0.57)/Emotion Regulation (r = -0.52), both p < 0.02), were also observed at end-trial.
E.F. Coccaro: Consultant; Self; Avanir, Inc. Other Relationship; Self; Azevan, Inc. A.K. Busby: None. T.M. Potts: None. L.H. Philipson: Research Support; Self; Jaeb Center for Health Research, Johnson & Johnson. T. Drossos: None.
Chicago Center for Diabetes Translation Research (P30DK092949); University of Chicago